LakeShore Ebit from 2010 to 2025
| LSBPW Stock | 0.06 0.02 54.49% |
EBIT | First Reported 2010-12-31 | Previous Quarter -369.8 M | Current Value -351.3 M | Quarterly Volatility 97.7 M |
Check LakeShore Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LakeShore Biopharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 37.9 M, Interest Expense of 29.6 M or Selling General Administrative of 130.7 M, as well as many indicators such as Price To Sales Ratio of 1.07, Dividend Yield of 0.0 or PTB Ratio of 1.05. LakeShore financial statements analysis is a perfect complement when working with LakeShore Biopharma Valuation or Volatility modules.
LakeShore | Ebit |
Latest LakeShore Biopharma's Ebit Growth Pattern
Below is the plot of the Ebit of LakeShore Biopharma Co, over the last few years. It is LakeShore Biopharma's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LakeShore Biopharma's overall financial position and show how it may be relating to other accounts over time.
| Ebit | 10 Years Trend |
|
Ebit |
| Timeline |
LakeShore Ebit Regression Statistics
| Arithmetic Mean | (183,451,789) | |
| Geometric Mean | 166,426,016 | |
| Coefficient Of Variation | (53.27) | |
| Mean Deviation | 72,691,590 | |
| Median | (144,682,070) | |
| Standard Deviation | 97,726,704 | |
| Sample Variance | 9550.5T | |
| Range | 312.5M | |
| R-Value | (0.60) | |
| Mean Square Error | 6572.8T | |
| R-Squared | 0.36 | |
| Significance | 0.01 | |
| Slope | (12,276,067) | |
| Total Sum of Squares | 143257.6T |
LakeShore Ebit History
Other Fundumenentals of LakeShore Biopharma Co,
About LakeShore Biopharma Financial Statements
LakeShore Biopharma investors use historical fundamental indicators, such as LakeShore Biopharma's Ebit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LakeShore Biopharma. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EBIT | -369.8 M | -351.3 M | |
| EBITDA | -331.8 M | -315.2 M | |
| Ebt Per Ebit | 1.17 | 1.22 | |
| Ebit Per Revenue | (0.89) | (0.85) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for LakeShore Stock Analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.